The U.S. government's decision to ease restrictions creates immediate opportunities for companies with Chinese supply chain dependencies. This policy shift could unlock previously constrained business operations and revenue streams.
Electronics distributors and semiconductor companies are experiencing renewed stability as regulatory uncertainty decreases. This restoration of critical global supply links could drive significant operational improvements and cost savings.
These stocks are uniquely positioned to benefit from evolving U.S.-China trade relations. As tensions ease and business normalises, companies with deep Chinese integration could see substantial performance improvements ahead of broader market recognition.
Market capitalisation breakdown for the basket focused on companies sensitive to US-China tech trade policy changes.
ARW: $6.14B
TSM: $1.23T
ASML: $397.24B
The U.S. government's decision to lift trade restrictions on major electronics distributors signals a potential shift towards a more nuanced approach to China trade policy. This creates opportunities for companies deeply integrated with Chinese manufacturing and distribution networks to benefit from reduced regulatory friction and more stable operations.
This group focuses on electronics component distributors, semiconductor manufacturers, and technology hardware companies whose business models rely heavily on Chinese supply chains. These firms are particularly sensitive to U.S.-China trade policy changes and could see improved financial performance as regulatory uncertainty decreases.
These companies were handpicked by professional analysts based on their significant exposure to Chinese manufacturing and distribution networks. They represent tactical investment opportunities positioned to benefit from easing trade tensions and the restoration of critical global supply chain links.
The U.S. government has lifted trade restrictions on Arrow Electronics' Chinese affiliates, restoring a critical link in the global electronics supply chain. This move signals a potential easing of trade tensions and benefits U.S. companies reliant on Chinese manufacturing and distribution.
Published on October 20
+6
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+8.41%
On average, analysts expect assets in this group to grow 8.41% over the next year.
11 of 16 assets in this group are rated Buy by professional analysts.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full Insight
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
